The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009483200 · Cited by 1,161
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Glycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829 · cited 1×
“Certainly, the observation that the glycosylation state of IgG influences the pro- or anti-inflammatory nature of IgG is consistent with the clinical observation that decreased levels of sialylation and galactosylation of IgG are seen in patients with inflammatory autoimmune diseases such as rheumatoid arthritis and v…”
Engineered antibody Fc variants with enhanced effector function
Lazar, G. A., Dang, W., Karki, S., Vafa, O., Peng, J. S., Hyun, L., Chan, C., Chung, H. S., Eivazi, A., Yoder, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508123103 · Cited by 803
Koene, H. R., Kleijer, M., Algra, J., Roos, D., E.G.Kr. von dem Borne, A., & de Haas, M. (1997) · Blood · doi:10.1182/blood.v90.3.1109 · Cited by 794
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
Dall'Acqua, W. F., Kiener, P. A., & Wu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604292200 · Cited by 646
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V. (2011) · Nature · doi:10.1038/nature10134 · Cited by 633
Yamane‐Ohnuki, N., Kinoshita, S., Inoue‐Urakubo, M., Kusunoki, M., Iida, S., Nakano, R., Wakitani, M., Niwa, R., Sakurada, M., Uchida, K., et al. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20151 · Cited by 572
Human neutrophil Fc gamma receptor distribution and structure.
Fleit, H. B., Wright, S. D., & Unkeless, J. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3275 · Cited by 564
FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
Smith, K. G. C., & Clatworthy, M. R. (2010) · Nature Reviews Immunology · doi:10.1038/nri2762 · Cited by 543
Bibeau, F., Lopez-Crapez, E., Di Fiore, F., Thezenas, S., Ychou, M., Blanchard, F., Lamy, A., Penault-Llorca, F., Frébourg, T., Michel, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0463 · Cited by 521
Braselmann, S., Taylor, V., Zhao, H., Wang, S., Sylvain, C., Baluom, M., Qu, K., Herlaar, E., Lau, A., Young, C., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.109058 · Cited by 508
Molecular Basis of Fc Receptor Function
Hulett, M. D., & Hogarth, P. M. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60671-9 · Cited by 505
Self-citationFanciulli, M., Norsworthy, P. J., Petretto, E., Dong, R., Harper, L., Kamesh, L., Heward, J. M., Gough, S. C. L., de Smith, A., Blakemore, A. I. F., et al. (2007) · Nature Genetics · doi:10.1038/ng2046 · Cited by 464
Refined Structure of an Intact IgG2a Monoclonal Antibody,
Harris, L. J., Larson, S. B., Hasel, K. W., & McPherson, A. (1997) · Biochemistry · doi:10.1021/bi962514+ · Cited by 451
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407
Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393
Clinical uses of intravenous immunoglobulin
Jolles, S., Sewell, W. A. C., & Misbah, S. A. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02834.x · Cited by 374
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., & Unkeless, J. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141907 · Cited by 365
Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα
Garman, S. C., Wurzburg, B. A., Tarchevskaya, S. S., Kinet, J.-P., & Jardetzky, T. S. (2000) · Nature · doi:10.1038/35018500 · Cited by 355
The Structure of a Human Type III Fcγ Receptor in Complex with Fc
Radaev, S., Motyka, S., Fridman, W.-H., Sautes-Fridman, C., & Sun, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100350200 · Cited by 354
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354
Yamamoto, K., Utsunomiya, A., Tobinai, K., Tsukasaki, K., Uike, N., Uozumi, K., Yamaguchi, K., Yamada, Y., Hanada, S., Tamura, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3575 · Cited by 354
Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90521-5 · Cited by 350
Kyogoku, C., Dijstelbloem, H. M., Tsuchiya, N., Hatta, Y., Kato, H., Yamaguchi, A., Fukazawa, T., Jansen, M. D., Hashimoto, H., van de Winkel, J. G. J., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10257 · Cited by 332
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Jefferis, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.04.007 · Cited by 330
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Human monocytes and U937 cells bear two distinct Fc receptors for IgG.
Looney, R. J., Abraham, G. N., & Anderson, C. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.5.1641 · Cited by 328
Deletion of Fcγ Receptor IIB Renders H-2b Mice Susceptible to Collagen-induced Arthritis
Yuasa, T., Kubo, S., Yoshino, T., Ujike, A., Matsumura, K., Ono, M., Ravetch, J. V., & Takai, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.187 · Cited by 325
Ferrara, C., Brünker, P., Suter, T., Moser, S., Püntener, U., & Umaña, P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20777 · Cited by 305
Ioan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M. M., van Lent, P. L., Hofhuis, F. M. A., van Ojik, H. H., Sedlik, C., da Silveira, S. A., Gerber, J., de Jong, Y. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00294-7 · Cited by 304
Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286
Antibody‐mediated modulation of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 285
Stavenhagen, J. B., Gorlatov, S., Tuaillon, N., Rankin, C. T., Li, H., Burke, S., Huang, L., Johnson, S., Bonvini, E., & Koenig, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0696 · Cited by 284
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1
Matsumiya, S., Yamaguchi, Y., Saito, J.-I., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., & Kato, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.034 · Cited by 278
Asano, K., Matsushita, T., Umeno, J., Hosono, N., Takahashi, A., Kawaguchi, T., Matsumoto, T., Matsui, T., Kakuta, Y., Kinouchi, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.482 · Cited by 276
Herr, A. B., Ballister, E. R., & Bjorkman, P. J. (2003) · Nature · doi:10.1038/nature01685 · Cited by 274
Transmembrane signaling: the joy of aggregation
Metzger, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.5.1477 · Cited by 273
Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates
Hinton, P. R., Johlfs, M. G., Xiong, J. M., Hanestad, K., Ong, K. C., Bullock, C., Keller, S., Tang, M. T., Tso, J. Y., Vásquez, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300470200 · Cited by 273
Lim, S. H., Vaughan, A. T., Ashton-Key, M., Williams, E. L., Dixon, S. V., Chan, H. T. C., Beers, S. A., French, R. R., Cox, K. L., Davies, A. J., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330357 · Cited by 267
Human Antibody Effector Function
Burton, D. R., & Woof, J. M. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60486-1 · Cited by 265
Podolanczuk, A., Lazarus, A. H., Crow, A. R., Grossbard, E., & Bussel, J. B. (2009) · Blood · doi:10.1182/blood-2008-07-166439 · Cited by 263
West, A. P., & Bjorkman, P. J. (2000) · Biochemistry · doi:10.1021/bi000749m · Cited by 257
Ballow, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 253
Wilson, N. S., Yang, B., Yang, A., Loeser, S., Marsters, S., Lawrence, D., Li, Y., Pitti, R., Totpal, K., Yee, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.012 · Cited by 248
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Siragam, V., Crow, A. R., Brinc, D., Song, S., Freedman, J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246
Hamaguchi, Y., Xiu, Y., Komura, K., Nimmerjahn, F., & Tedder, T. F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052283 · Cited by 237
Fc Receptors and Their Role in Immune Regulation and Autoimmunity
Takai, T. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0353-8 · Cited by 231
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
White, A. L., Chan, H. T. C., Roghanian, A., French, R. R., Mockridge, C. I., Tutt, A. L., Dixon, S. V., Ajona, D., Verbeek, J. S., Al-Shamkhani, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101135 · Cited by 226
Baker, K., Qiao, S.-W., Kuo, T. T., Aveson, V. G., Platzer, B., Andersen, J.-T., Sandlie, I., Chen, Z., de Haar, C., Lencer, W. I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019037108 · Cited by 216
Pritchard, N. R., Cutler, A. J., Uribe, S., Chadban, S. J., Morley, B. J., & Smith, K. G. C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00344-4 · Cited by 210
Farag, S. S., Flinn, I. W., Modali, R., Lehman, T. A., Young, D., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2003-07-2548 · Cited by 210
FcγRI-Deficient Mice Show Multiple Alterations to Inflammatory and Immune Responses
Barnes, N., Gavin, A. L., Tan, P. S., Mottram, P., Koentgen, F., & Hogarth, P. M. (2002) · Immunity · doi:10.1016/s1074-7613(02)00287-x · Cited by 207
Self-citationKenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., Ikle, D. N., Yazaki, P. J., Chatziioannou, A. F., Gambhir, S. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.622.65.2 · Cited by 206
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
Hogarth, P. M., Maxwell, K. F., Powell, M. S., Hulett, M. D., Bartoň, P., McKenzie, I. F. C., & Garrett, T. (1999) · Nature Structural Biology · doi:10.1038/8241 · Cited by 195
Self-citationWeng, W.-K., Czerwinski, D., Timmerman, J., Hsu, F. J., & Levy, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.003 · Cited by 191
Fc receptors are major mediators of antibody based inflammation in autoimmunity
Hogarth, P. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00409-0 · Cited by 189
Self-citationTsuboi, N., Asano, K., Lauterbach, M., & Mayadas, T. N. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.013 · Cited by 180
Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus
Su, K., Yang, H., Li, X., Li, X., Gibson, A. W., Cafardi, J. M., Zhou, T., Edberg, J. C., & Kimberly, R. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3272 · Cited by 179
Lifely, M. R., Hale, C., Boyce, S., Keen, M. J., & Phillips, J. (1995) · Glycobiology · doi:10.1093/glycob/5.8.813 · Cited by 178
Aglycosylated immunoglobulin G1variants productively engage activating Fc receptors
Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 177
A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling
Li, X., Wu, J., Carter, R. H., Edberg, J. C., Su, K., Cooper, G. S., & Kimberly, R. P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11313 · Cited by 176
CD23/FcεRII: molecular multi-tasking
Acharya, M., Borland, G., Edkins, A. L., MacLellan, L. M., Matheson, J., Ozanne, B. W., & Cushley, W. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04210.x · Cited by 175
Albert, H., Collin, M., Dudziak, D., Ravetch, J. V., & Nimmerjahn, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808248105 · Cited by 175
O'Neill, S. K., Getahun, A., Gauld, S. B., Merrell, K. T., Tamir, I., Smith, M. J., Dal Porto, J. M., Li, Q.-Z., & Cambier, J. C. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.011 · Cited by 165
Clatworthy, M. R., Willcocks, L., Urban, B., Langhorne, J., Williams, T. N., Peshu, N., Watkins, N. A., Floto, R. A., & Smith, K. G. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608889104 · Cited by 164
Chapter 4 Multitasking by Exploitation of Intracellular Transport Functions
Ward, E. S., & Ober, R. J. (2009) · Advances in immunology · doi:10.1016/s0065-2776(09)03004-1 · Cited by 163
Ramsland, P. A., Farrugia, W., Bradford, T. M., Sardjono, C. T., Esparon, S., Trist, H. M., Powell, M. S., Tan, P. S., Cendron, A. C., Wines, B. D., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101467 · Cited by 163
Self-citationThe C1q receptor site on immunoglobulin G
Burton, D. R., Boyd, J., Brampton, A. D., Easterbrook-Smith, S. B., Emanuel, E. J., Novotny, J., Rademacher, T. W., van Schravendijk, M. R., Sternberg, M. J. E., & Dwek, R. A. (1980) · Nature · doi:10.1038/288338a0 · Cited by 159
Prabhat, P., Gan, Z., Chao, J., Ram, S., Vaccaro, C., Gibbons, S., Ober, R. J., & Ward, E. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700337104 · Cited by 157
Wines, B. D., Powell, M. S., Parren, P. W. H. I., Barnes, N. C., & Hogarth, P. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5313 · Cited by 152
Self-citationda Silva, F. P., Aloulou, M., Skurnik, D., Benhamou, M., Andremont, A., Velasco, I. T., Chiamolera, M., Verbeek, J. S., Launay, P., & Monteiro, R. C. (2007) · Nature Medicine · doi:10.1038/nm1665 · Cited by 146
Copy number, linkage disequilibrium and disease association in the FCGR locus
Niederer, H. A., Willcocks, L., Rayner, T., Yang, W.-L., Lau, Y.-L., Williams, T., Scott, J., Urban, B., Peshu, N., Dunstan, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq216 · Cited by 146
Inhibition of Immune Responses by ITAM-Bearing Receptors
Hamerman, J. A., & Lanier, L. L. (2006) · Science s STKE · doi:10.1126/stke.3202006re1 · Cited by 143
Maenaka, K., van der Merwe, P. A., Stuart, D. I., Jones, E. Y., & Sondermann, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106819200 · Cited by 138
Recognition of IgG by Fcγ Receptor
Radaev, S., & Sun, P. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100351200 · Cited by 138
FcγRIIa, Not FcγRIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells
Zhao, W., Kepley, C. L., Morel, P. A., Okumoto, L. M., Fukuoka, Y., & Schwartz, L. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.694 · Cited by 132
In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling
de Haij, S., Jansen, J. H. M., Boross, P., Beurskens, F. J. M., Bakema, J. E., Bos, D. L., Martens, A. C., Verbeek, J. S., Parren, P. W. H. I., van de Winkel, J. G. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4109 · Cited by 130
Sondermann, P., Huber, R., & Jacob, U. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1095 · Cited by 123
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
Bergtold, A., Gavhane, A., D’Agati, V. D., Madaio, M. P., & Clynes, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7287 · Cited by 122
Cheung, N. V., Sowers, R. S., Vickers, A. J., Cheung, I. Y., Kushner, B. H., & Gorlick, R. G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6011 · Cited by 122
Vaccaro, C., Bawdon, R. E., Wanjie, S., Ober, R. J., & Ward, E. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606304103 · Cited by 117
Dougherty, G. J., Selvendran, Y., Murdoch, S., Palmer, D. G., & Hogg, N. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171011 · Cited by 116
The Role of Antibodies in Mouse Models of Rheumatoid Arthritis, and Relevance to Human Disease
Monach, P. A., Benoist, C. O., & Mathis, D. J. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82005-4 · Cited by 112
Kepley, C. L., Taghavi, S., Mackay, G. A., Zhu, D., Morel, P. A., Zhang, K., Ryan, J. J., Satin, L. S., Zhang, M., Pandolfi, P. P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404318200 · Cited by 112
Evolution of anti- CD20 monoclonal antibody therapeutics in oncology
Oflazoglu, E., & Audoly, L. (2010) · mAbs · doi:10.4161/mabs.2.1.10789 · Cited by 109
Cady, C. T., Powell, M. S., Harbeck, R. J., Giclas, P. C., Murphy, J. R., Katial, R. K., Weber, R. W., Hogarth, P. M., Johnson, S., Bonvini, E., et al. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.12.001 · Cited by 97
Self-citationExpression of FcγRIII is required for development of collagen-induced arthritis
de Ståhl, T. D., Andrén, M., Martinsson, P., Verbeek, J. S., & Kleinau, S. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2915::aid-immu2915>3.0.co;2-4 · Cited by 96
Bakema, J. E., & van Egmond, M. (2011) · mAbs · doi:10.4161/mabs.3.4.16092 · Cited by 96
Schuster, M., Umaña, P., Ferrara, C., Brünker, P., Gerdes, C. A., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4212 · Cited by 91
Crystal Structure of Fcγ Receptor I and Its Implication in High Affinity γ-Immunoglobulin Binding
Lu, J., Ellsworth, J. L., Hamacher, N. B., Oak, A. S. W., & Sun, P. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257550 · Cited by 89
Ierino, F. L., Powell, M. S., McKenzie, I. F. C., et al. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.5.1617 · Cited by 89
Rankin, C. T., Verı́, M.-C., Gorlatov, S. N., Tuaillon, N., Burke, S., Huang, L., Inzunza, H. D., Li, H., Thomas, S., Johnson, S., et al. (2006) · Blood · doi:10.1182/blood-2006-05-020602 · Cited by 88
Kurlander, R. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.1.140 · Cited by 86
Baudino, L., Nimmerjahn, F., da Silveira, S. A., Martínez-Soria, E., Saito, T., Carroll, M. C., Ravetch, J. V., Verbeek, J. S., & Izui, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1948 · Cited by 84
Routier, F. H., Hounsell, E. F., Rudd, P. M., Takahashi, N., Bond, A., Hay, F. C., Alavi, A., Axford, J. S., & Jefferis, R. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00032-5 · Cited by 83
Sardjono, C. T., Mottram, P. L., van de Velde, N. C., Powell, M. S., Power, D. A., Slocombe, R. F., Wicks, I. P., Campbell, I. K., McKenzie, S. E., Brooks, M., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21344 · Cited by 80
Self-citationLin, T. S., Flinn, I. W., Modali, R., Lehman, T. A., Webb, J. L., Waymer, S., Moran, M. E., Lucas, M. S., Farag, S. S., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-02-0651 · Cited by 80
Tsuboi, N., Ernandez, T., Li, X., Nishi, H., Culleré, X., Mekala, D. J., Hazen, M. M., Köhl, J., Lee, D. M., & Mayadas, T. N. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30141 · Cited by 78
Pfirsch, S., Aloulou, M., Xu, T., Claver, J., Kanamaru, Y., Tiwari, M. K., Launay, P., Monteiro, R. C., & Blank, U. (2011) · Science Signaling · doi:10.1126/scisignal.2001309 · Cited by 78
Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
Bakema, J. E., Ganzevles, S. H., Fluitsma, D. M., Schilham, M. W., Beelen, R. H. J., Valerius, T., Lohse, S., Glennie, M. J., Medema, J. P., & van Egmond, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002581 · Cited by 75
Mullazehi, M., Mathsson, L., Lampa, J., & Rönnelid, J. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21892 · Cited by 73
Mechanisms of action of intravenous immunoglobulins
Baerenwaldt, A., Biburger, M., & Nimmerjahn, F. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.9 · Cited by 65
van der Poel, C. E., Karssemeijer, R. A., Boross, P., van der Linden, J. A., Blokland‐Fromme, M., van de Winkel, J. G. J., & Leusen, J. H. W. (2010) · Blood · doi:10.1182/blood-2010-04-280214 · Cited by 64
Modulation of antibody effector function
Desjarlais, J. R., & Lazar, G. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.018 · Cited by 63
Ericson, S. G., Coleman, K. D., Wardwell, K., Baker, S., Fanger, M. W., Guyre, P. M., & Ely, P. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.393931.x · Cited by 57
Dunn-Siegrist, I., Léger, O. J. P., Daubeuf, B., Poitevin, Y., Dépis, F., Herren, S., Kosco‐Vilbois, M. H., Dean, Y. D., Pugin, J., & Elson, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706440200 · Cited by 51
Alizadeh, B. Z., Valdigem, G., Coenen, M. J. H., Zhernakova, A., Franke, B., Monsuur, A. J., van Riel, P. L. C. M., Barrera, P., Radstake, T. R. D. J., Roep, B. O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm194 · Cited by 51
Nakamura, G. R., Starovasnik, M. A., Reynolds, M. E., & Lowman, H. B. (2001) · Biochemistry · doi:10.1021/bi0109360 · Cited by 50
Stable “zeta” peptides that act as potent antagonists of the high-affinity IgE receptor
Nakamura, G. R., Reynolds, M. E., Chen, Y. M., Starovasnik, M. A., & Lowman, H. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022635599 · Cited by 49
van Berkel, P. H. C., Gerritsen, J., van Voskuilen, E., Perdok, G. J., Vink, T., van de Winkel, J. G. J., & Parren, P. W. H. I. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22535 · Cited by 48
A New Ligand for Immunoglobulin G Subdomains by Screening of a Synthetic Peptide Library
Verdoliva, A., Marasco, D., Capua, A. D., Saporito, A., Bellofiore, P., Manfredi, V., Fattorusso, R., Pedone, C., & Ruvo, M. (2005) · ChemBioChem · doi:10.1002/cbic.200400368 · Cited by 47
Inhibition of destructive autoimmune arthritis in FcγRIIa transgenic mice by small chemical entities
Pietersz, G. A., Mottram, P. L., van de Velde, N. C., Sardjono, C. T., Esparon, S. E., Ramsland, P. A., Moloney, G. M., Baell, J. B., McCarthy, T. D., Matthews, B. R., et al. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.82 · Cited by 44
Self-citationMezo, A. R., Sridhar, V., Badger, J., Sakorafas, P., & Nienaber, V. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.120667 · Cited by 43
Shashidharamurthy, R., Hennigar, R. A., Fuchs, S., Palaniswami, P., Sherman, M. A., & Selvaraj, P. (2007) · Blood · doi:10.1182/blood-2007-04-085944 · Cited by 40
Biochemical analysis and crystallisation of FcγRIIa, the low affinity receptor for IgG
Powell, M. S., Barton, P. A., Emmanouilidis, D., et al. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00025-5 · Cited by 39
Amelioration of collagen-induced arthritis by human recombinant soluble FcγRIIb
Magnusson, S. E., Andrén, M., Nilsson, K. E., Sondermann, P., Jacob, U., & Kleinau, S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.02.002 · Cited by 38
X-ray crystallographic studies of IgG-Fcγ receptor interactions
Sondermann, P., & Oosthuizen, V. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300481 · Cited by 35
van de Velde, N. C., Mottram, P. L., Powell, M. S., Lim, B., Holmdahl, R., & Hogarth, P. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.12.005 · Cited by 33
Self-citationFcγRIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma
Dharajiya, N. G., Vaidya, S. V., Murai, H., Cardenas, V. J., Kurosky, A., Boldogh, I. R., & Sur, S. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009337 · Cited by 33
Wallace, P. K., Keler, T., Coleman, K. D., Fisher, J. L., Vitale, L. A., Graziano, R. F., Guyre, P. M., & Fanger, M. W. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.4.469 · Cited by 30
In vivo veritas: the surprising roles of Fc receptors in immunity
Ravetch, J. V. (2010) · Nature Immunology · doi:10.1038/ni0310-183 · Cited by 27
Weersma, R., Crusius, B., Roberts, R., Koeleman, B., Palomino-Morales, R., Wolfkamp, S. C. S., Hollis-Moffatt, J. E., Festen, E., Meisneris, S., Heijmans, R., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21342 · Cited by 27
Kacskovıcs, I., Cervenak, J., Erdei, A., Goldsby, R. A., & Butler, J. E. (2011) · mAbs · doi:10.4161/mabs.3.5.17023 · Cited by 20
Rigby, L. J., Trist, H. M., Snider, J., Hulett, M. D., Hogarth, P. M., Rigby, L. J., & Epa, V. C. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00485.x · Cited by 19
Self-citationThe structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors
Sondermann, P., & Oosthuizen, V. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00018-4 · Cited by 18
Cady, C. T., Rice, J. S., Ott, V. L., & Cambier, J. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00663.x · Cited by 18
Zhuang, Y., Xu, W., Shen, Y., & Li, J. (2010) · Clinical Lymphoma Myeloma & Leukemia · doi:10.3816/clml.2010.n.067 · Cited by 17
Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer
Nakamura, A., Akiyama, K., & Takai, T. (2005) · Expert opinion on therapeutic targets · doi:10.1517/14728222.9.1.169 · Cited by 15
Characterization of an FcγRI-binding peptide selected by phage display
Berntzen, G., Brekke, O. H., Mousavi, S. A., Andersen, J. T., Michaelsen, T. E., Berg, T., Sandlie, I., & Lauvrak, V. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzj011 · Cited by 13
Berntzen, G., Andersen, J. T., Ustgård-Andersen, K., Michaelsen, T. E., Mousavi, S. A., Qian, J. D., Kristiansen, P. E., Lauvrak, V., & Sandlie, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803584200 · Cited by 10
Cited by
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab, I., & Nimmerjahn, F. (2013) · Nature Reviews Immunology · doi:10.1038/nri3401 · Cited by 820
Bulliard, Y., Jolicoeur, R., Windman, M., Rue, S. M., Ettenberg, S., Knee, D. A., Wilson, N. S., Dranoff, G., & Brogdon, J. L. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130573 · Cited by 446
Schlothauer, T., Herter, S., Koller, C. F., Grau-Richards, S., Steinhart, V., Spick, C., Kubbies, M., Klein, C., Umaña, P., & Mössner, E. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw040 · Cited by 425
SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions
Pucci, F., Garris, C., Lai, C. P., Newton, A., Pfirschke, C., Engblom, C., Alvarez, D., Sprachman, M., Evavold, C., Magnuson, A., et al. (2016) · Science · doi:10.1126/science.aaf1328 · Cited by 349
Irani, V., Guy, A. J., Andrew, D., Beeson, J. G., Ramsland, P. A., & Richards, J. S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.255 · Cited by 288
Metadata
- Authors
- Hogarth, P. M., & Pietersz, G. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-03-30
- Volume
- 11
- Issue
- 4
- Pages
- 311-331
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2041944580
- Cited by
- 348
- References
- 148
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.